It takes a lot of courage to grow old. I’ve come to appreciate this after conversations with hundreds of older adults over the past eight years for nearly 200 “Navigating Aging” columns.
Larimar Therapeutics shares key biomarker data, aims for accelerated approval for Friedreich’s ataxia drug
Larimar Therapeutics announced Monday that its Friedreich’s ataxia treatment increased median levels of a key protein called frataxin in a mid-stage study. The biotech is
February 13, 2024